Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-31

Clinical Trial Update: Different Dosage Regimens of Methocarbamol/Paracetamol in Acute Non-specific Low Back Pain. MioPain Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (MioPain) evaluating different dosage regimens of methocarbamol/paracetamol for acute non-specific low back pain was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methocarbamol/paracetamol (methocarbamol and paracetamol fixed-dose combination)

Snippet

Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A | Conditions: Low Back Pain | Phase 4 | Status: TERMINATED